Results: In stage I (1718 patients, 6288 prescriptions): 61.69% patients experienced at least 1 PIM and 41.09% experienced at least 1 PPO, 36.26% prescriptions experienced at least 1 PIM and 27.66% experienced at least 1 PPO.